(R)-2-((PHENYLCARBAMOYL)OXY)PROPANOIC ACID, 95.0%, 50g

Benzonitrile, 4-[5-[(1E)-2-[4-(2-chlorophenyl)-5-[5-(methylsulfonyl)-2-pyridinyl]-4H-1,2,4-triazol-3-yl]ethenyl]-1,3,4-oxadiazol-2-yl]-, 25mg

Asa de inoculación, 5,45 mm 25 uds.

7-bromo-6-fluoro-1,4-dihydroquinazolin-4-one, 97%, 250mg

Ethyl 2-cyclohexylacetate, 95.0%, 25g

4-(Pentafluorosulfur)phenol, 95.0%, 5g

(4-((4-Ethylpiperazin-1-yl)sulfonyl)phenyl)boronic acid, 98%, 1g

1-(1-(Benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea, 95.0%, 250mg

8-chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 99.00%, 1g

4-(3-methylphenyl)piperidin-4-ol, 95.0%, 250mg

2-Methylbutyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate, 95.0%, 50mg

2-(Ethylamino)ethanol>98.0%(GC)(T)500mL

1,2,3,4-Tetrahydroquinolin-8-amine, 95+%, 1g